109 related articles for article (PubMed ID: 18580060)
1. The relationship of plasminogen activator inhibitor-1 levels to the ST deviation pattern of acute myocardial infarction.
Rott D; Leibowitz D; Finci-Yeheskel Z; Barak V; Chajek-Shaul T; Weiss T; Levin M; Urieli-Shoval S
Cardiology; 2009; 112(1):56-9. PubMed ID: 18580060
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic status in acute coronary syndromes: evidence of differences in relation to clinical features and pathophysiological pathways.
Shantsila E; Montoro-García S; Tapp LD; Apostolakis S; Wrigley BJ; Lip GY
Thromb Haemost; 2012 Jul; 108(1):32-40. PubMed ID: 22538774
[TBL] [Abstract][Full Text] [Related]
4. Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction.
Figueras J; Monasterio J; Lidón RM; Sambola A; Garcia-Dorado D
Thromb Res; 2012 Sep; 130(3):458-62. PubMed ID: 22424853
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.
García-García C; Subirana I; Sala J; Bruguera J; Sanz G; Valle V; Arós F; Fiol M; Molina L; Serra J; Marrugat J; Elosua R
Am J Cardiol; 2011 Oct; 108(8):1061-7. PubMed ID: 21791326
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction.
Chaudhuri A; Janicke D; Wilson MF; Tripathy D; Garg R; Bandyopadhyay A; Calieri J; Hoffmeyer D; Syed T; Ghanim H; Aljada A; Dandona P
Circulation; 2004 Feb; 109(7):849-54. PubMed ID: 14757687
[TBL] [Abstract][Full Text] [Related]
7. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality.
Collet JP; Montalescot G; Vicaut E; Ankri A; Walylo F; Lesty C; Choussat R; Beygui F; Borentain M; Vignolles N; Thomas D
Circulation; 2003 Jul; 108(4):391-4. PubMed ID: 12860898
[TBL] [Abstract][Full Text] [Related]
8. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
Stefanadi E; Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Vavuranakis E; Triantafyllou G; Marinou K; Tsioufis C; Papageorgiou N; Latsios G; Stefanadis C
Int J Cardiol; 2009 Apr; 133(2):266-8. PubMed ID: 18187214
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification in patients with unstable angina and/or non-ST-elevation myocardial infarction by Troponin T and plasminogen-activator-inhibitor-1 (PAI-1).
Sinkovic A; Pogacar V
Thromb Res; 2004; 114(4):251-7. PubMed ID: 15381388
[TBL] [Abstract][Full Text] [Related]
10. Management and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the Malopolska Registry of Acute Coronary Syndromes.
Dziewierz A; Siudak Z; Dykla D; Rakowski T; Mielecki W; Dubiel JS; Dudek D
Kardiol Pol; 2009 Feb; 67(2):115-20; discussion 121-2. PubMed ID: 19288373
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.
Maier W; Altwegg LA; Corti R; Gay S; Hersberger M; Maly FE; Sütsch G; Roffi M; Neidhart M; Eberli FR; Tanner FC; Gobbi S; von Eckardstein A; Lüscher TF
Circulation; 2005 Mar; 111(11):1355-61. PubMed ID: 15753219
[TBL] [Abstract][Full Text] [Related]
12. Left circumflex artery-related myocardial infarction: does ST elevation matter? Results from the Euro Heart Survey PCI registry.
Bauer T; Gitt AK; Hochadel M; Möllmann H; Nef H; Weidinger F; Zahn R; Hamm CW; Marco J; Zeymer U
Int J Cardiol; 2013 Oct; 168(6):5239-42. PubMed ID: 23998547
[TBL] [Abstract][Full Text] [Related]
13. ST-deviation patterns in recurrent myocardial infarctions.
Rott D; Weiss AT; Chajek-Shaul T; Leibowitz D
Am J Cardiol; 2006 Jul; 98(1):10-3. PubMed ID: 16784911
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
15. Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.
Wiviott SD; Morrow DA; Frederick PD; Antman EM; Braunwald E;
J Am Coll Cardiol; 2006 Apr; 47(8):1553-8. PubMed ID: 16630990
[TBL] [Abstract][Full Text] [Related]
16. Identification and predictive value of interleukin-6+ interleukin-10+ and interleukin-6- interleukin-10+ cytokine patterns in ST-elevation acute myocardial infarction.
Ammirati E; Cannistraci CV; Cristell NA; Vecchio V; Palini AG; Tornvall P; Paganoni AM; Miendlarzewska EA; Sangalli LM; Monello A; Pernow J; Björnstedt Bennermo M; Marenzi G; Hu D; Uren NG; Cianflone D; Ravasi T; Manfredi AA; Maseri A
Circ Res; 2012 Oct; 111(10):1336-48. PubMed ID: 22931953
[TBL] [Abstract][Full Text] [Related]
17. Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction.
Park HW; Yoon CH; Kang SH; Choi DJ; Kim HS; Cho MC; Kim YJ; Chae SC; Yoon JH; Gwon HC; Ahn YK; Jeong MH;
Int J Cardiol; 2013 Nov; 169(4):254-61. PubMed ID: 24071385
[TBL] [Abstract][Full Text] [Related]
18. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes.
Passoni F; Morelli B; Seveso G; Lazzati L; Beria G; Del Rosso G; D'Urbano M; Cafiero F; Mariani G; De Servi S
Ital Heart J; 2002 Jan; 3(1):28-33. PubMed ID: 11899586
[TBL] [Abstract][Full Text] [Related]
19. Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction.
Zairis MN; Lyras AG; Bibis GP; Patsourakos NG; Makrygiannis SS; Kardoulas AD; Glyptis MP; Prekates AA; Cokkinos DV; Foussas SG
Atherosclerosis; 2005 Sep; 182(1):161-7. PubMed ID: 16115487
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome.
Novo G; Assennato P; Caruso M; Turturici C; Balistreri CR; Amoroso GR; Fazio G; Rotolo A; Coppola G; Hoffmann E; Caruso C; Novo S
Minerva Cardioangiol; 2009 Feb; 57(1):7-11. PubMed ID: 19202515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
